Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
General Information
Revision date
2019-04-04
Product name
Kyprolis (carfilzomib)
Product Synonyms
Carfilzomib
Emergency telephone
1-800-424-9300, 1-703-527-3887, 1-805-447-7233, 1-805-447-1000
Icons in SDS
Company Information
company name
Amgen Inc
Section 2
SECTION 2: Hazards identification
Classification According to Directive 67/548/EEC or 1999/45/EC: Emergency Overview Pharmaceutical product intended for clinical and manufacturing purposes only. Product contains carfilzomib, an active pharmaceutical ingredient, for treatment of multiple myeloma. Dosage contents may pose a health hazard only if significant absorption occurs (e.g. inhalation after a major spill). Avoid inhalation, skin contact, eye contact, and accidental ingestions. Based on available data, the GHS classification criteria are not met. 2.1 - Classification of the drug substance or mixture (drug product in final form, not applicable) REGULATION (EC) No 1272/2008 Does not meet GHS classification criteria and therefore is not classified.
EU Classification
Directives 67/548/EEC or 1999/45/EC For the full text of the R phrases mentioned in this Section, see Section 16
2.2 Label elements
Does not meet GHS classification criteria and therefore is not classified.
Other hazards
No information available
